Clinical Trial Update: Evaluation of BIS for Quantification of Lymphedema

View source ↗

Summary

Clinical trial update reports results for evaluating bioimpedance spectroscopy (BIS) to quantify lymphedema in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lymphedema

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Breast Cancer | Status: COMPLETED | Results posted: 2021-11-17